So, not only is Northwest BioTherapeuticsproducing a personalizedvaccine to the individual patient, but it's alsostoringa3yearstock pile for that patientatlowcost.
The British Medical Association has dismissed this, arguing they had been warning stocks were running low for weeks and claiming not all of the doses may have gone to GPs - pharmacists and primary care trusts also stock the vaccine.
As I said, anything -- could go for something as repaying for the defraying of cost to move diagnostic and screening equipment or public health infrastructure, the purchase of and development of more antiviral medication, or as we get into the development of a seed stock for a vaccine.